Len Zehr
Contributor since: 2011
In Conversation With Pivotal Therapeutics
XTL Hopes To Begin Major Lupus Trial Next Year
Opexa Is Personalizing The Treatment Of Autoimmune Disease
Transition Moves Into Late-Stage Drug Development
Venaxis's Pivotal Data Due In March
Alcobra's ADHD Program Moving To Pediatrics
In Conversation With Bing Yao
Heat Biologics Readies Proof-Of-Concept Studies
CytRx Awaiting Soft Tissue Sarcoma Data In December
Tonix Developing Treatment Overlap For Fibromyalgia And PTSD
Kelly Close: State Of Diabetes Treatment, Companies In The Sector And Challenges Patients Face
DiaDexus Awaiting GSK's Darapladib Pivotal Results
Galectin Targets Silent Epidemic In Liver Fibrosis
RedHill Readying Phase III Trials In Crohn's
In Conversation With Cancer Genetics CEO Panna Sharma
Soligenix Readies 2 Drugs For Key Trials This Year
Synthetic Biologics' Sniper Approach To Infectious Diseases
Zalicus Awaiting Data On Potential New Pain Medication
Galena Targets Cancer Pain Market
Oramed Readies Oral Insulin Study In U.S.
BioLineRx Pipeline Returns To The Winner's Circle
BioDelivery On Track For Mid-Year NDA Filing
OncoGenex's Second Cancer Drug Gaining Investor Attention
Sucampo Should See Revenue From 3 Continents By Year-End
All Eyes On Ohr Pharma Wet AMD Study
Prima BioMed To Get Key Data In Second Half
Rockwell Medical Readying 2 Drugs For Dialysis
Novadaq Highlights Game Changer For The OR
Transition Therapeutics Awaiting Competing AD Trial Results
IntelGenx Striving To Create A Second Biovail
Pluristem Pioneering Intramuscular Placenta-Based Cell Therapies
AMRI Turnaround At Inflection Point